Loading stock data…
STSS
$1.84+0.06 (+3.08%)
Market ClosedLast close May 1
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sharps Technology, Inc. in the Healthcare sector is trading at $1.84. The stock is currently near its 52-week low of $1.42, remaining 53.9% below its 200-day moving average. Technical signals show neutral RSI of 57 and bullish MACD crossover, explaining why STSS maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 57) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.84
Potential Upside
5%
Whystock Fair Value$1.93
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The comp...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$69.21M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.07
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-106.85%
Volume
Today's trading volume
314,353
Recent News
From MedTech to SOL Machine: Why Sharps Technology Just Landed on Crypto Radar
Sharps Technology (NASDAQ: $STSS) is making a move few saw coming. Known as a medical-device company, Sharps is now...
Crypto Currents: Strategy, Galaxy Digital report Q4 earnings results
As bitcoin, ethereum and other cryptocurrencies see major legal, institutional, and technological developments, the financial landscape continues to adapt. Stay up on the crypto news that matters with the “Crypto Currents” weekly from The Fly. Also, join us for your essential daily recap, every day at 2 PM ET on FlyCast radio.Valentine's Day Sale - 70% OffUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and ana
Sharps Technology Earns Solana Staking Income Even as SOL Slides
Public company Sharps Technology reportedly earned income from staking Solana while the price of SOL kept sliding. The contrast stands out because it shows how crypto can still generate yield even during a downturn. It also comes during a rough stretch for altcoins, where falling prices have scared many first-time ...
Sharps Taps Coinbase Validator—Why Solana Staking Is Shifting
Sharps Technology, a publicly listed medical device firm with a large SOL treasury, hired Coinbase to launch and operate its own Solana validator. SOL traded around $145, up roughly 2% on the day, as staking-related news added to a steady institutional bid. The move fits a wider trend where companies ...
Sharps Technology Taps Coinbase to Launch Solana Validator
Sharps Technology has taken a vital step into blockchain infrastructure with the launch of a Solana validator. As detailed, it will be leaning on Coinbase to handle operations as the medical device company shifts from holding digital assets to supporting the network itself. Coinbase Takes Lead in Validator Operations The ...